The ORA has published an official position statement on biosimilar non-medical switching. To review this important document, please visit this link: Official Position
Other Articles in the Summer 2018 Newsletter
- ORADE Grant Recipient - Dr. Konstantin Jilkine
- President's Message
- Canada's Drug Scene: National Pharmacare, Drug Shortages and More
- ORADE Grant Recipient: Dr. Pat Ciaschini
- ORA Meets with pCPA and CHLIA
- Post a Locum or Apply for One!
- OMA Section on Rheumatology Report
- Communication Update
- Emerging Rheumatologists of Ontario (ERO) Committee
The ORA’s executive members are the core contributors to the newsletter. The ORA welcomes guest contributions to the newsletter from members-at-large and others in the rheumatology community.